• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    RadNet Announces the Agenda for its November 11, 2025 Investor Day

    11/4/25 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care
    Get the next $RDNT alert in real time by email

    LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and a premier global developer of digital health solutions, is pleased to unveil the agenda for the company's Investor Day.

    The event will take place on Tuesday, November 11, 2025 from 9:00 a.m. to 2:30 p.m. Eastern Standard Time at the Nasdaq MarketSite in New York City. In-person attendance is by invitation only and investors can request such consideration by emailing [email protected]. Those unable to participate onsite can view a live webcast at https://edge.media-server.com/mmc/p/rz6bqgzd/ or see an archived replay of the event in the Investor Relations section of RadNet's website.

    Titled "On the Leading Edge of Healthcare: Advancing Imaging Through Innovation and Technology," the Investor Day will feature presentations from select RadNet senior executives and clinical leaders who will share the company's current and longer-term strategic priorities, market opportunities and innovation roadmap.

    The agenda is as follows:

    • 9:00 to 9:20 a.m. – Opening Remarks and Financial Overview
    • 9:20 to 11:00 a.m. – Expert Clinical Spotlights and Services Division Presentation
    • 11:00 to 11:30 a.m. – Q&A Session
    • 12:15 to 1:15 p.m. – Digital Health Division Presentation
    • 1:15 to 1:45 p.m. – Discussion About Unique Synergy of Services and Digital Health
    • 1:45 to 1:55 p.m. – Value-Creation Plan Towards 2028
    • 2:00 to 2:30 p.m. – Q&A Session

    In-person attendees will have the exclusive opportunity to engage with RadNet's leadership, talk with clinical and research experts and view the following demonstrations of RadNet's DeepHealth cloud-native AI products:

    • Breast Suite – A portfolio of solutions designed to enhance quality, workflows and other aspects of diagnosing breast cancer.
    • Diagnostic Suite – Imaging platform that unites picture archiving and communications systems (PACS), multi-modality viewing, automated reporting, workflow tools and various AI-empowered clinical processes.
    • TechLive™ – Vendor-agnostic, remote scanning and radiology management solution designed to extend expert support for MR, ultrasound, CT and PET/CT across large, multi-site operations.
    • Patient Engagement – A portfolio of solutions aimed at improving patient scheduling, onboarding, follow-up interactions and online payments.

    About RadNet, Inc.

    RadNet, Inc. is a leading provider of outpatient diagnostic imaging services in the United States, with a network of 405 owned and/or operated imaging centers. The company's markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. For more information, visit www.radnet.com.

    Contact:

    RadNet, Inc.

    Mark Stolper

    Executive Vice President and Chief Financial Officer

    310-445-2928

    Or

    Jane Mazur

    Senior Vice President, Corporate Communications

    [email protected]

    Investor Relations:

    Addo IR

    [email protected]



    Primary Logo

    Get the next $RDNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RDNT

    DatePrice TargetRatingAnalyst
    1/9/2026$92.00Overweight
    KeyBanc Capital Markets
    6/13/2025$69.00Buy
    B. Riley Securities
    3/5/2025$85.00 → $65.00Outperform → Strong Buy
    Raymond James
    9/6/2024$57.00 → $79.00Equal Weight → Overweight
    Barclays
    3/6/2024$48.00Equal Weight
    Barclays
    8/31/2023$40.00Buy
    Truist
    3/31/2023$30.00Market Outperform
    CJS Securities
    3/3/2023$30.00Mkt Perform → Outperform
    Raymond James
    More analyst ratings

    $RDNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RadNet, Inc. to Present Today at the KeyBanc Capital Markets Healthcare Forum

    LOS ANGELES, March 17, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). There will be simultaneous and archived webcasts available at https://wsw.com/webcast/key40/rdnt/1686072 About RadNet, Inc.RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of

    3/17/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet, Inc. to Present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12th

    LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12, 2026 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). There will be simultaneous and archived webcasts available at https://urldefense.com/v3/__https://cc.webcasts.com/barc002/031026a_js/?entity=144_X3VLDEI__;!!COmMWt7_Sw!XlHi2Z0Y8oljWTGFQhCAlqx-WUpj99UPNp1_sposW-TqahO41Keizcqhw9B4eULlXCe9bGpTDgrQlnQ9cI0$ Det

    3/11/26 4:15:00 PM ET
    $RDNT
    Medical Specialities
    Health Care

    DeepHealth Unveils Industry's Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026

    VIENNA, March 04, 2026 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ:RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of native clinical AI solutions and services across all core imaging modalities — MR, CT, X-ray, Mammography and Ultrasound — and spanning detection, assessment and monitoring, all available on one platform. With this week's acquisition of Gleamer, DeepHealth further expands its leadership in advancing screening tools into routine imaging and acute diagnostic care, uniquely positioned to deliver the next era of AI-powered health informatics.  "As European na

    3/4/26 7:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets initiated coverage on RadNet with a new price target

    KeyBanc Capital Markets initiated coverage of RadNet with a rating of Overweight and set a new price target of $92.00

    1/9/26 9:07:04 AM ET
    $RDNT
    Medical Specialities
    Health Care

    B. Riley Securities initiated coverage on RadNet with a new price target

    B. Riley Securities initiated coverage of RadNet with a rating of Buy and set a new price target of $69.00

    6/13/25 7:50:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet upgraded by Raymond James with a new price target

    Raymond James upgraded RadNet from Outperform to Strong Buy and set a new price target of $65.00 from $85.00 previously

    3/5/25 7:50:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by RadNet Inc.

    SCHEDULE 13G/A - RadNet, Inc. (0000790526) (Subject)

    3/27/26 11:35:46 AM ET
    $RDNT
    Medical Specialities
    Health Care

    SEC Form 10-K filed by RadNet Inc.

    10-K - RadNet, Inc. (0000790526) (Filer)

    3/2/26 5:17:51 PM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - RadNet, Inc. (0000790526) (Filer)

    3/2/26 7:01:44 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sorensen Alma Gregory

    4 - RadNet, Inc. (0000790526) (Issuer)

    3/23/26 4:15:05 PM ET
    $RDNT
    Medical Specialities
    Health Care

    SEC Form 4 filed by Sorensen Alma Gregory

    4 - RadNet, Inc. (0000790526) (Issuer)

    3/18/26 7:38:51 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Chief Strategy Officer Sorensen Alma Gregory converted options into 62,964 shares, increasing direct ownership by 5% to 1,244,842 units (SEC Form 4)

    4 - RadNet, Inc. (0000790526) (Issuer)

    3/12/26 5:52:02 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Leadership Updates

    Live Leadership Updates

    View All

    The Oncology Institute Announces Addition of Board Member Mark Stolper

    CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Mark Stolper has joined the Board of Directors, effective January 2, 2026. Mr. Stolper brings significant public markets, financial and operational leadership experience to The Oncology Institute's board. Mr. Stolper serves as Executive Vice President and Chief Financial Officer of RadNet, Inc. (NASDAQ:RDNT), a position he has held since 2004. Mr. Stolper has also been a member of the Board of Directors of various publicly traded and privately held healthcare companies, including 21st Century Oncolog

    1/5/26 8:30:00 AM ET
    $RDNT
    $TOI
    Medical Specialities
    Health Care
    Medical/Nursing Services

    RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division

    Former Chief Business Leader of Philips' multi-billion-dollar Precision Diagnosis division and member of Philips' Executive CommitteeEnd-to-end responsibility for Philip's CT, MR, dXR, Ultrasound and Diagnostic Informatics (radiology software) businessesProven track record of building and managing radiology software solutions, including significant experience with AI development and commercialization LOS ANGELES, Sept. 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers and digital health solutions, announced today the appo

    9/12/24 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    11/12/24 4:51:53 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    11/4/24 1:22:38 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    10/24/24 6:36:21 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Financials

    Live finance-specific insights

    View All

    RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS

    LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, reminds investors that on Thursday, March 5, 2026, investors are invited to join a dedicated conference call and presentation to hear more details about the recently completed acquisition of Gleamer SAS and RadNet's Digital Health strategy. On the call, investors will also have the opportunity to ask questions of executive management. Investor Call Details: The conference call will take place at 7:30 a.m. Pacific Time/10:30 am. Eastern Time/4:30 p.m. Centr

    3/4/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA⁽¹⁾ and Releases 2026 Financial Guidance

    Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 48.2% to $27.9 million in the fourth quarter of 2025 from $18.9 million in the fourth quarter of 2024Total Company Adjusted EBITDA(1) was a quarterly record of $87.7 million in the fourth quarter of 2025 as compared with $75.0 million in the fourth quarter of 2024, an increase of 16.9%; Digital Health reportable segment Adjusted EBITDA(1) increased 8.9% to $4.9 million in the fourth quarter of 2025 from $4.5 million in the fourth quarter of

    3/2/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Acquires Gleamer, Making RadNet's DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide

    Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for musculoskeletal, breast, lung and neurologic applications.Gleamer's leadership in routine imaging, and particularly X-ray, is unparalleled through the breadth and scale of its cloud-first AI solutions. DeepHealth, combined with Gleamer's solutions will provide the industry's most comprehensive portfolio of native clinical AI solutions and services across all core imaging modalities. Gleamer achieved an Annual Recurring Revenue ("ARR") i compound annual growth rate exceeding 90% from 2022 through 2025 and is expected to reach approximately $30 millio

    3/2/26 5:45:00 AM ET
    $RDNT
    Medical Specialities
    Health Care